Ex-Pharma CEO's FBAR Violation Was Willful, 3rd Circ. Told

By Natalie Olivo · October 18, 2021, 8:00 PM EDT

The U.S. government urged the Third Circuit against revisiting a former pharmaceutical executive's dispute over $1 million in penalties for failing to report an offshore bank account, arguing that a district...

To view the full article, register now.